FindTrial
Sign In

A study to evaluate the factors which predicts the survival of lung cancer patients with their performance status.

â??An observational study to evaluate factors predicting survival in patients of NSCLC with compromised PS.â??

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2014/11/005216
Enrollment
250
Registered
2014-11-21
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients of Advanced Lung Cancer

Interventions

Intervention1: Not Applicable: Not Applicable Control Intervention1: Not Applicable: Not Applicable

Sponsors

Tata Memorial Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: • Diagnosis: - Histopathological or cytological proven NSCLC. • PS: - 3, 4 • Chemotherapy naive. • Intent of therapy is palliative. • Age > 18 years

Exclusion criteria

Exclusion criteria: No Exclusion criteria

Design outcomes

Primary

MeasureTime frame
To study the factors affecting the outcome (Overall Survival) of all NSCLC patients with compromised PS (PS2) whether offered treatment or not. Timepoint: 6 months—

Secondary

MeasureTime frame
1) Evaluate if active therapy improves the quality of life of patients with NSCLC with compromised PS 2) Evaluate the toxicity of treatment administered to patients with NSCLC with compromised PS. Timepoint: 6 months—

Countries

India

Contacts

Public ContactDr Amit Joshi

Tata Memorial Hospital

dramit74@yahoo.com9769331525

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026